64. 血栓性血小板減少性紫斑病 Thrombotic thrombocytopenic purpura Clinical trials / Disease details


臨床試験数 : 92 薬物数 : 85 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 76

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05135442
(ClinicalTrials.gov)
December 1, 20216/11/2021Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTPThe Efficacy and Safety of Bortezomib as First-line Treatment for Acquired Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpura, AcquiredDrug: Bortezomib InjectionPeking Union Medical College HospitalNULLNot yet recruiting18 Years80 YearsAll30Phase 4China